PMC5766343

Cervical cancer survivors had a substantially higher risk of preterm birth in their first live singleton birth conceived after diagnosis, with 28% of births delivered before 37 weeks compared to match

Effect: decline; RR=2.8; CI: 95% CI: 2.1, 3.7

Cervical cancer survivors had a substantially higher risk of preterm birth in their first live singleton birth conceived after diagnosis, with 28% of births delivered before 37 weeks compared to match

Effect: decline; RR=2.8; CI: 95% CI: 2.1, 3.7

Cervical cancer survivors had a substantially higher risk of preterm birth in their first live singleton birth conceived after diagnosis, with 28% of births delivered before 37 weeks compared to match

Effect: decline; RR=2.8; CI: 95% CI: 2.1, 3.7

Cervical cancer survivors had a substantially higher risk of preterm birth in their first live singleton birth conceived after diagnosis, with 28% of births delivered before 37 weeks compared to match

Effect: decline; RR=2.8; CI: 95% CI: 2.1, 3.7

Cervical cancer survivors had a substantially higher risk of preterm birth in their first live singleton birth conceived after diagnosis, with 28% of births delivered before 37 weeks compared to match

Effect: decline; RR=2.8; CI: 95% CI: 2.1, 3.7

Cervical cancer survivors had a substantially higher risk of preterm birth in their first live singleton birth conceived after diagnosis, with 28% of births delivered before 37 weeks compared to match

Effect: decline; RR=2.8; CI: 95% CI: 2.1, 3.7

Cervical cancer survivors had a substantially higher risk of preterm birth in their first live singleton birth conceived after diagnosis, with 28% of births delivered before 37 weeks compared to match

Effect: decline; RR=2.8; CI: 95% CI: 2.1, 3.7

Cervical cancer survivors had a substantially higher risk of preterm birth in their first live singleton birth conceived after diagnosis, with 28% of births delivered before 37 weeks compared to match

Effect: decline; RR=2.8; CI: 95% CI: 2.1, 3.7

Cervical cancer survivors had a substantially higher risk of preterm birth in their first live singleton birth conceived after diagnosis, with 28% of births delivered before 37 weeks compared to match

Effect: decline; RR=2.8; CI: 95% CI: 2.1, 3.7

Cervical cancer survivors had a substantially higher risk of preterm birth in their first live singleton birth conceived after diagnosis, with 28% of births delivered before 37 weeks compared to match

Effect: decline; RR=2.8; CI: 95% CI: 2.1, 3.7

Cervical cancer survivors had a substantially higher risk of preterm birth in their first live singleton birth conceived after diagnosis, with 28% of births delivered before 37 weeks compared to match

Effect: decline; RR=2.8; CI: 95% CI: 2.1, 3.7

Cervical cancer survivors had a substantially higher risk of preterm birth in their first live singleton birth conceived after diagnosis, with 28% of births delivered before 37 weeks compared to match

Effect: decline; RR=2.8; CI: 95% CI: 2.1, 3.7

Cervical cancer survivors had a substantially higher risk of preterm birth in their first live singleton birth conceived after diagnosis, with 28% of births delivered before 37 weeks compared to match

Effect: decline; RR=2.8; CI: 95% CI: 2.1, 3.7

Cervical cancer survivors had a substantially higher risk of preterm birth in their first live singleton birth conceived after diagnosis, with 28% of births delivered before 37 weeks compared to match

Effect: decline; RR=2.8; CI: 95% CI: 2.1, 3.7

Cervical cancer survivors had a substantially higher risk of preterm birth in their first live singleton birth conceived after diagnosis, with 28% of births delivered before 37 weeks compared to match

Effect: decline; RR=2.8; CI: 95% CI: 2.1, 3.7

Cervical cancer survivors had a substantially higher risk of preterm birth in their first live singleton birth conceived after diagnosis, with 28% of births delivered before 37 weeks compared to match

Effect: decline; RR=2.8; CI: 95% CI: 2.1, 3.7

Cervical cancer survivors had a substantially higher risk of preterm birth in their first live singleton birth conceived after diagnosis, with 28% of births delivered before 37 weeks compared to match

Effect: decline; RR=2.8; CI: 95% CI: 2.1, 3.7

Cervical cancer survivors had a substantially higher risk of preterm birth in their first live singleton birth conceived after diagnosis, with 28% of births delivered before 37 weeks compared to match

Effect: decline; RR=2.8; CI: 95% CI: 2.1, 3.7

Cervical cancer survivors had a substantially higher risk of preterm birth in their first live singleton birth conceived after diagnosis, with 28% of births delivered before 37 weeks compared to match

Effect: decline; RR=2.8; CI: 95% CI: 2.1, 3.7

Cervical cancer survivors had a substantially higher risk of preterm birth in their first live singleton birth conceived after diagnosis, with 28% of births delivered before 37 weeks compared to match

Effect: decline; RR=2.8; CI: 95% CI: 2.1, 3.7

Cervical cancer survivors had a substantially higher risk of preterm birth in their first live singleton birth conceived after diagnosis, with 28% of births delivered before 37 weeks compared to match

Effect: decline; RR=2.8; CI: 95% CI: 2.1, 3.7

Cervical cancer survivors had a substantially higher risk of preterm birth in their first live singleton birth conceived after diagnosis, with 28% of births delivered before 37 weeks compared to match

Effect: decline; RR=2.8; CI: 95% CI: 2.1, 3.7

Cervical cancer survivors had a substantially higher risk of preterm birth in their first live singleton birth conceived after diagnosis, with 28% of births delivered before 37 weeks compared to match

Effect: decline; RR=2.8; CI: 95% CI: 2.1, 3.7

Cervical cancer survivors had a substantially higher risk of preterm birth in their first live singleton birth conceived after diagnosis, with 28% of births delivered before 37 weeks compared to match

Effect: decline; RR=2.8; CI: 95% CI: 2.1, 3.7

Cervical cancer survivors had a substantially higher risk of preterm birth in their first live singleton birth conceived after diagnosis, with 28% of births delivered before 37 weeks compared to match

Effect: decline; RR=2.8; CI: 95% CI: 2.1, 3.7

Cervical cancer survivors had a substantially higher risk of preterm birth in their first live singleton birth conceived after diagnosis, with 28% of births delivered before 37 weeks compared to match

Effect: decline; RR=2.8; CI: 95% CI: 2.1, 3.7

Cervical cancer survivors had a substantially higher risk of preterm birth in their first live singleton birth conceived after diagnosis, with 28% of births delivered before 37 weeks compared to match

Effect: decline; RR=2.8; CI: 95% CI: 2.1, 3.7

Survivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6

Survivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6

Survivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6

Survivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6

Survivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6

Survivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6

Survivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6

Survivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6

Survivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6

Survivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6

Survivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6

Survivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6

Survivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6

Survivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6

Survivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6

Survivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6

Survivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6

Survivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6

Survivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6

Survivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6

Survivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6

Survivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6

Survivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6